Aflac Inc (AFL)
102.69
+1.44
(+1.42%)
USD |
NYSE |
Dec 20, 16:00
102.12
-0.57
(-0.56%)
Pre-Market: 20:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 57.05B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | 29.95% |
| Valuation | |
| PE Ratio | 15.47 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 3.372 |
| Price to Book Value | 2.298 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | 0.58 |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.3169 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 54.88% |
Profile
| Aflac Inc offers supplemental health insurance and life insurance in United States and Japan. In addition to its cancer policies, the company has broadened its product offerings to include accident, dental and vision, disability, and long-term-care insurance. It markets its products through independent distributors, selling majority of its policies directly to consumers at their places of work and also reaches out to its customers out of their worksite through digital mediums. The company has two reportable business segments; Aflac Japan which generates the majority of the revenue, and Aflac U.S. |
| URL | https://www.aflac.com |
| Investor Relations URL | https://investors.aflac.com |
| HQ State/Province | Georgia |
| Sector | Financials |
| Industry | Insurance |
| Equity Style | Mid Cap/Blend |
| Next Earnings Release | Jan. 31, 2025 (est.) |
| Last Earnings Release | Oct. 30, 2024 |
| Next Ex-Dividend Date | Feb. 19, 2025 |
| Last Ex-Dividend Date | Nov. 20, 2024 |
Ratings
Profile
| Aflac Inc offers supplemental health insurance and life insurance in United States and Japan. In addition to its cancer policies, the company has broadened its product offerings to include accident, dental and vision, disability, and long-term-care insurance. It markets its products through independent distributors, selling majority of its policies directly to consumers at their places of work and also reaches out to its customers out of their worksite through digital mediums. The company has two reportable business segments; Aflac Japan which generates the majority of the revenue, and Aflac U.S. |
| URL | https://www.aflac.com |
| Investor Relations URL | https://investors.aflac.com |
| HQ State/Province | Georgia |
| Sector | Financials |
| Industry | Insurance |
| Equity Style | Mid Cap/Blend |
| Next Earnings Release | Jan. 31, 2025 (est.) |
| Last Earnings Release | Oct. 30, 2024 |
| Next Ex-Dividend Date | Feb. 19, 2025 |
| Last Ex-Dividend Date | Nov. 20, 2024 |